This educational activity is intended for an international audience of non-US and non-UK diabetologists, endocrinologists, cardiologists, and primary care physicians.
The goal of this activity is to increase physician awareness of key clinical study results with long-acting glucagon-like peptide 1 (GLP-1) receptor agonists.
Upon completion of this activity, participants will:
WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.
The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.25 continuing professional development credits (CPD).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information about your
eligibility to claim credit, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must
complete the activity online during the credit eligibility period that is noted on the title page.
Follow these steps to claim a credit certificate for completing this activity:
We encourage you to complete an Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.
*The credit that you receive is based on your user profile.
CPD Released: 7/10/2020
Valid for credit through: 7/10/2021, 11:59 PM EST
processing....
ADA = American Diabetes Association
AE = adverse event
ALT = alanine aminotransferase (ALT)
AST = aspartate aminotransferase
BMI = body mass index
DKD = diabetic kidney disease
DPP-4 = dipeptidyl peptidase 4
DSST = Digit Symbol Substitution Test
eGFR = estimated glomerular filtration rate
GFR = glomerular filtration rate
GI = gastrointestinal
GIP = glucose-dependent insulinotropic polypeptide
GLP-1 = glucagon-like peptide 1
K-18 = keratin-18
MACE = major adverse cardiac events
MoCA = Montreal Cognitive Assessment
OAD = oral antidiabetic drug
PBO = placebo
Pro-C3 = procollagen III
RA = receptor agonist
SD = standard deviation
SGLT-2 = sodium-glucose co-transporter-2
SU = sulfonylurea
T2D = type 2 diabetes
TZD = thiazolidinedione
UACR = urinary albumin-creatinine ratio
« Return to: A Digest of Latest Clinical Data With GLP-1 Receptor Agonists |